Generic filters
Filter by content type
Taxonomy terms

MAXE – Max Healthcare Institute Ltd


Subscribe for full access

Unlock Industry-grade Shariah Compliance for US, UK, Canada, Germany, GCC, Europe and India. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.

Get started from just $1/month


Recommendation Rating







1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL

Analysts’ Price Targets

Mean 5.45

Low: 5.16

High: 5.78

Total Analysts: 7

Company Profile

Max Healthcare Institute Limited is an India-based healthcare company. The Company is specialized in providing treatment for cancer care / oncology, cardiac sciences, neurosciences, liver transplant and biliary sciences, orthopaedics, nephrology, kidney transplant, bone marrow transplant, bariatric/weight loss surgery and minimal access / laparoscopic surgery. Max@Home is a platform that provides health and wellness services at home and MaxLab offers pathology services to patients outside of its hospitals through a variety of channels, including third-party hospital laboratory management. It also provides treatment for Bone marrow transplant, brain stroke treatment, brain tumor surgery, breast reduction surgery, cardiac valve replacement surgery, cataract surgery, chemotherapy, coronary angioplasty, coronary artery bypass grafting, kidney transplant, laparoscopic urologic surgery, lithotripsy, liver transplant, lung transplant, pacemaker implantation and prostate laser surgery.

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan